A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes.
Influenza A virus (IAV) predisposes individuals to often more severe secondary bacterial infections with Streptococcus pneumonia (S. pneumoniae). The outcomes of these infections may be made worse with the increase in antimicrobial resistance and a lack of new treatments to combat this. Th17 respons...
Enregistré dans:
Auteurs principaux: | Paula T Maguire, Sinéad T Loughran, Ruth Harvey, Patricia A Johnson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/126bb045368d4fa68f4b6426253b4b4b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Contextualization procedure and modeling of monocyte specific TLR signaling.
par: Maike K Aurich, et autres
Publié: (2012) -
Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease
par: Zhiming Wang, et autres
Publié: (2020) -
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
par: Sathana Dushyanthen, et autres
Publié: (2017) -
Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry
par: Takahiro Sawada, et autres
Publié: (2021) -
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
par: Zhang,Li, et autres
Publié: (2015)